DEANXIT

This brand name is authorized in Austria, Cyprus, Spain, Hong Kong, Malta, Singapore

Active ingredients

The drug DEANXIT contains a combination of these active pharmaceutical ingredients (APIs):

1 Melitracen UNII J3448GKP5W - MELITRACEN HYDROCHLORIDE

Melitracen is a tricyclic antidepressant with activating properties in low doses. It has similar pharmacological properties as amitriptyline but is less sedative. Read about Melitracen

2 Flupentixol UNII HAT84MLQ6Z - FLUPENTIXOL DIHYDROCHLORIDE

Read about Flupentixol

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
DEANXIT Film-coated tablet	Υπουργείο Υγείας (CY)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N06CA02	Melitracen and psycholeptics	N Nervous system → N06 Psychoanaleptics → N06C Psycholeptics and psychoanaleptics in combination → N06CA Antidepressants in combination with psycholeptics
Discover more medicines within N06CA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 50102
Country: HK	Department of Health Drug Office	Identifier(s): 19697
Country: MT	Medicines Authority	Identifier(s): MA601/00401, PI908/04601A
Country: SG	Health Sciences Authority	Identifier(s): 00913P